Susquehanna International Securities, Ltd. Morpho Sys Ag Transaction History

Susquehanna International Securities, Ltd.

  • $389 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024
SELL
$8.6 - $18.18 $1.83 Million - $3.86 Million
-212,242 Reduced 74.92%
71,041 $1.29 Million
Q4 2023

Feb 14, 2024
BUY
$4.55 - $9.9 $1.29 Million - $2.8 Million
283,283 New
283,283 $2.8 Million

Others Institutions Holding MOR

# of Institutions
11
Shares Held
1.67M
Call Options Held
0
Put Options Held
14.7K
View Full List

About MorphoSys AG

MOR Quotes by TradingView
  • Ticker MOR
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 136,614,000
  • Description
  • MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...
More about MOR
Track This Portfolio

Track Susquehanna International Securities, Ltd. Portfolio

Follow Susquehanna International Securities, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Securities, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Securities, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email